• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全科医疗中的恶性高血压

Malignant hypertension in general practice.

作者信息

Bulpitt C J, Bulpitt P F, Clark P B, Crombie D L, Lambert P, Dollery C T

出版信息

J R Coll Gen Pract. 1985 Oct;35(279):471-5.

PMID:4078797
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1960286/
Abstract

A diagnosis of malignant hypertension was recorded for 165 patients in the national morbidity study between 1970 and 1973. Three patients with benign hypertension were selected as age- and sex-matched controls for each case. The general practitioners in the study were asked to complete a further questionnaire about the patients and 66% of the practices agreed to take part. Information about the retinal findings for the patients was requested and less than half of those in the national morbidity study proved to have a strict diagnosis of accelerated or malignant hypertension although they were originally recorded as patients with malignant hypertension. Of those patients originally classified as having benign hypertension 5% had the retinal appearance of accelerated or malignant hypertension.Patients had been diagnosed as having hypertension for a mean of more than five years prior to entry into the national morbidity study and the survival of patients with both benign and accelerated or malignant hypertension was good. Thirtyfour per cent of those with confirmed benign hypertension and 62% of those with definite accelerated or malignant hypertension died in the follow-up period which was on average 10 years from entry into the national morbidity study.The survival of patients registered with doctors who did not collaborate and of patients whose clinical details were missing was similar to the survival of patients for whom full details were provided.Blood pressure control was only fair with a mean of 172/101 mmHg for the group with benign hypertension and 177/107 mmHg for the group with accelerated or malignant hypertension. Blood pressure control was the poorest for those who died from a stroke. A high proportion (78%) of deaths in association with accelerated or malignant hypertension were from cardiovascular or renal causes.

摘要

在1970年至1973年的全国发病率研究中,记录了165例恶性高血压患者的诊断情况。为每例患者选取3例年龄和性别匹配的良性高血压患者作为对照。研究中的全科医生被要求填写一份关于患者的进一步问卷,66%的医疗机构同意参与。研究人员索要了患者的视网膜检查结果,结果发现,尽管最初被记录为恶性高血压患者,但在全国发病率研究中,不到一半的患者被严格诊断为急进性或恶性高血压。在最初被归类为良性高血压的患者中,5%有急进性或恶性高血压的视网膜表现。在进入全国发病率研究之前,患者被诊断为高血压的平均时间超过5年,良性高血压以及急进性或恶性高血压患者的生存率都较好。在随访期(平均从进入全国发病率研究起10年),确诊为良性高血压的患者中有34%死亡,确诊为急进性或恶性高血压的患者中有62%死亡。未参与合作的医生所登记患者以及临床细节缺失患者的生存率与提供了完整细节患者的生存率相似。血压控制情况一般,良性高血压组的平均血压为172/101 mmHg,急进性或恶性高血压组为177/107 mmHg。因中风死亡的患者血压控制最差。与急进性或恶性高血压相关的死亡中,很大一部分(78%)是由心血管或肾脏原因导致的。

相似文献

1
Malignant hypertension in general practice.全科医疗中的恶性高血压
J R Coll Gen Pract. 1985 Oct;35(279):471-5.
2
Long-term prognosis in malignant or accelerated hypertension.恶性或急进性高血压的长期预后
Nephrol Dial Transplant. 1988;3(1):33-7.
3
NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).香豆素(CAS编号91-64-5)在F344/N大鼠和B6C3F1小鼠中的NTP毒理学和致癌性研究(灌胃研究)
Natl Toxicol Program Tech Rep Ser. 1993 Sep;422:1-340.
4
Factors influencing mortality in malignant hypertension.影响恶性高血压死亡率的因素。
J Hypertens Suppl. 1985 Dec;3(3):S405-7.
5
NTP Toxicology and Carcinogenesis Studies of Phenolphthalein (CAS No. 77-09-8) in F344/N Rats and B6C3F1 Mice (Feed Studies).酚酞(CAS编号:77-09-8)在F344/N大鼠和B6C3F1小鼠中的NTP毒理学和致癌性研究(饲料研究)
Natl Toxicol Program Tech Rep Ser. 1996 Nov;465:1-354.
6
The failure of malignant hypertension to decline: a survey of 24 years' experience in a multiracial population in England.恶性高血压发病率居高不下:对英格兰多民族人群24年经验的调查。
J Hypertens. 1994 Nov;12(11):1297-305.
7
Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.预防性卵巢切除术:降低美国上皮性卵巢癌死亡率。一场持续的争论。
Oncologist. 1996;1(5):326-330.
8
Incidence and natural history of Paget's disease of bone in England and Wales.英格兰和威尔士骨佩吉特病的发病率及自然史。
J Bone Miner Res. 2002 Mar;17(3):465-71. doi: 10.1359/jbmr.2002.17.3.465.
9
Low mortality from all causes, including myocardial infarction, in well-controlled hypertensives treated with a beta-blocker plus other antihypertensives.在接受β受体阻滞剂加其他抗高血压药物治疗的血压控制良好的高血压患者中,包括心肌梗死在内的各种原因导致的死亡率较低。
J Hypertens. 1987 Aug;5(4):489-98.
10
NTP Toxicology and Carcinogenesis Studies of 2,3-Dibromo-1-Propanol (CAS No. 96-13-9) in F344/N Rats and B6C3F1 Mice (Dermal Studies).2,3-二溴-1-丙醇(CAS编号:96-13-9)对F344/N大鼠和B6C3F1小鼠的NTP毒理学与致癌性研究(皮肤研究)
Natl Toxicol Program Tech Rep Ser. 1993 Dec;400:1-202.

本文引用的文献

1
Results of treatment in malignant hypertension: a seven-year experience in 94 cases.恶性高血压的治疗结果:94例患者的七年经验
Br Med J. 1959 Nov 14;2(5158):969-80. doi: 10.1136/bmj.2.5158.969.
2
Some aspects of prognosis in treated hypertension.经治疗高血压的预后的某些方面。
Br Med J. 1959 May 30;1(5134):1368-73. doi: 10.1136/bmj.1.5134.1368.
3
Hypertension: treated and untreated; a study of 400 cases.高血压:已治疗与未治疗;400例病例研究。
Br Med J. 1959 May 30;1(5134):1361-8. doi: 10.1136/bmj.1.5134.1361.
4
Prognosis of treated hypertension. Changes in life expectancy and causes of death between 1952 and 1967.高血压治疗的预后。1952年至1967年间预期寿命的变化及死亡原因。
Q J Med. 1970 Jul;39(155):411-29.
5
Childbirth preparation and outcomes of labor and delivery in primiparous women.初产妇的分娩准备及分娩结局
J Fam Pract. 1985 Apr;20(4):375-8.